Literature DB >> 25434378

Stereotactic laser ablation of high-grade gliomas.

Ammar H Hawasli1, Albert H Kim, Gavin P Dunn, David D Tran, Eric C Leuthardt.   

Abstract

Evolving research has demonstrated that surgical cytoreduction of a high-grade glial neoplasm is an important factor in improving the prognosis of these difficult tumors. Recent advances in intraoperative imaging have spurred the use of stereotactic laser ablation (laser interstitial thermal therapy [LITT]) for intracranial lesions. Among other targets, laser ablation has been used in the focal treatment of high-grade gliomas (HGGs). The revived application of laser ablation for gliomas parallels major advancements in intraoperative adjuvants and groundbreaking molecular advances in neuro-oncology. The authors review the research on stereotactic LITT for the treatment of HGGs and provide a potential management algorithm for HGGs that incorporates LITT in clinical practice.

Entities:  

Keywords:  BBB = blood-brain barrier; BCNU = carmustine; GBM = glioblastoma multiforme; GTR = gross-total resection; HGG = high-grade glioma; KPS = Karnofsky Performance Scale; LITT = laser interstitial thermal therapy; glioblastoma; glioma; laser ablation; laser interstitial thermal therapy; minimally invasive surgery

Mesh:

Year:  2014        PMID: 25434378     DOI: 10.3171/2014.9.FOCUS14471

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  33 in total

Review 1.  Strategies to target drugs to gliomas and CNS metastases of solid tumors.

Authors:  B Milojkovic Kerklaan; O van Tellingen; A D R Huitema; J H Beijnen; W Boogerd; J H M Schellens; D Brandsma
Journal:  J Neurol       Date:  2015-10-17       Impact factor: 4.849

Review 2.  Laser applications in surgery.

Authors:  Beina Azadgoli; Regina Y Baker
Journal:  Ann Transl Med       Date:  2016-12

3.  Laser Interstitial Thermal Therapy.

Authors:  Bhuvic Patel; Albert H Kim
Journal:  Mo Med       Date:  2020 Jan-Feb

4.  Image-guided resection of glioblastoma in eloquent brain areas facilitated by laser surface thermal therapy: clinical outcomes and long-term results.

Authors:  Artem Rozumenko; Valentyn Kliuchka; Volodymir Rozumenko; Vera Semenova; Sergii Kolesnyk; Zoja Fedorenko
Journal:  Neurosurg Rev       Date:  2018-01-22       Impact factor: 3.042

5.  Photothermal therapy of glioblastoma multiforme using multiwalled carbon nanotubes optimized for diffusion in extracellular space.

Authors:  Brittany N Eldridge; Brian W Bernish; Cale D Fahrenholtz; Ravi Singh
Journal:  ACS Biomater Sci Eng       Date:  2016-05-09

Review 6.  Emerging Applications of Therapeutic Ultrasound in Neuro-oncology: Moving Beyond Tumor Ablation.

Authors:  David S Hersh; Anthony J Kim; Jeffrey A Winkles; Howard M Eisenberg; Graeme F Woodworth; Victor Frenkel
Journal:  Neurosurgery       Date:  2016-11       Impact factor: 4.654

Review 7.  The effect of thermal therapy on the blood-brain barrier and blood-tumor barrier.

Authors:  Bhuvic Patel; Peter H Yang; Albert H Kim
Journal:  Int J Hyperthermia       Date:  2020-07       Impact factor: 3.914

Review 8.  Hyperthermia treatment advances for brain tumors.

Authors:  Georgios P Skandalakis; Daniel R Rivera; Caroline D Rizea; Alexandros Bouras; Joe Gerald Jesu Raj; Dominique Bozec; Constantinos G Hadjipanayis
Journal:  Int J Hyperthermia       Date:  2020-07       Impact factor: 3.914

Review 9.  In vitro evidence for glioblastoma cell death in temperatures found in the penumbra of laser-ablated tumors.

Authors:  Joshua D Frenster; Shivang Desai; Dimitris G Placantonakis
Journal:  Int J Hyperthermia       Date:  2020-07       Impact factor: 3.914

10.  Indications and Efficacy of Gamma Knife Stereotactic Radiosurgery for Recurrent Glioblastoma: 2 Decades of Institutional Experience.

Authors:  Brandon S Imber; Ishan Kanungo; Steve Braunstein; Igor J Barani; Shannon E Fogh; Jean L Nakamura; Mitchel S Berger; Edward F Chang; Annette M Molinaro; Juan R Cabrera; Michael W McDermott; Penny K Sneed; Manish K Aghi
Journal:  Neurosurgery       Date:  2017-01-01       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.